↓ Skip to main content

ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer

Overview of attention for article published in Breast Cancer Research, August 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#35 of 2,054)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
17 news outlets
twitter
1 X user

Citations

dimensions_citation
136 Dimensions

Readers on

mendeley
160 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
Published in
Breast Cancer Research, August 2021
DOI 10.1186/s13058-021-01462-3
Pubmed ID
Authors

Jamie O. Brett, Laura M. Spring, Aditya Bardia, Seth A. Wander

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 160 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 9%
Student > Bachelor 12 8%
Other 11 7%
Student > Master 11 7%
Researcher 8 5%
Other 24 15%
Unknown 79 49%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 25 16%
Medicine and Dentistry 20 13%
Agricultural and Biological Sciences 7 4%
Unspecified 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Other 10 6%
Unknown 90 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 114. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2023.
All research outputs
#367,563
of 25,392,582 outputs
Outputs from Breast Cancer Research
#35
of 2,054 outputs
Outputs of similar age
#9,626
of 434,809 outputs
Outputs of similar age from Breast Cancer Research
#1
of 24 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,809 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.